Ketospray Forte(KETOSpray)
Ketoprofen
Ketospray Forte and KETOSpray are different trade names for the same medicine.
Ketospray Forte contains the active substance ketoprofen, which belongs to the group of non-steroidal anti-inflammatory drugs (NSAIDs).
The indication for the use of Ketospray Forte is local, symptomatic treatment of pain and inflammation of soft tissues (including after sprains, strains, and bruises).
The efficacy and safety of using the medicine in children have not been established. Ketospray Forte should not be used in children under 15 years of age.
You should tell your doctor about all medicines you are currently taking or have recently taken, as well as any medicines you plan to take.
The occurrence of interactions between Ketospray Forte, used topically on the skin, and other medicines is unlikely, as the concentration of ketoprofen in the blood after topical use is very low.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, you should consult a doctor or pharmacist before using this medicine.
Ketospray Forte should notbe used in women during the last three months of pregnancy (III trimester).
During the first six months of pregnancy (I and II trimester), the medicine should not be used unless the doctor considers its use absolutely necessary. If treatment is necessary during this period, the smallest possible dose should be used for the shortest possible time.
The medicine should be used with caution and only in cases where it is absolutely necessary.
Oral forms (e.g., tablets) containing ketoprofen may cause side effects in the unborn child. It is not known whether the same risk occurs with the use of Ketospray Forte on the skin.
It is not known whether ketoprofen passes into breast milk in nursing women. Therefore, the use of Ketospray Forte is not recommended in breastfeeding women.
There are no data on the effect of ketoprofen, used topically on the skin, on the ability to drive and use machines.
100 mg of propylene glycol in 1 ml of liquid. Propylene glycol may cause skin irritation.
This medicine should always be used as directed by your doctor. If you are unsure, you should consult a doctor or pharmacist.
Ketospray Forte is used in adults and children over 15 years of age.
The usual dose is 3 to 6 sprays of the medicine on the affected area, two to three times a day.
The medicine should not be used for more than 7 days. If there is no improvement, you should consult a doctor.
The maximum daily dose is 18 sprays, which corresponds to 360 mg of ketoprofen.
Instructions for using the medicine.
Overdose of the medicine is unlikely due to the topical route of administration.
In case of using a higher dose of the medicine than recommended, the skin surface should be washed with water.
In case of accidental ingestion of the medicine, systemic side effects of varying severity may occur, depending on the amount of medicine taken (headaches and dizziness, nausea, vomiting, abdominal pain, drowsiness). Ingestion of large doses may cause respiratory depression, coma, convulsions, gastrointestinal bleeding, increased or decreased blood pressure, acute renal failure. There is no specific antidote. In such a case, you should immediately consult a doctor or pharmacist.
If a dose of the medicine is missed, it should be used as soon as possible, and then the usual dosing schedule should be followed.
A double dose should not be used to make up for a missed dose of the medicine.
If you have any further doubts about using this medicine, you should consult a doctor or pharmacist.
Like all medicines, Ketospray Forte can cause side effects, although not everybody gets them.
Side effects after topical use of ketoprofen occur infrequently or rarely.
They include allergic skin reactions, severe skin reactions caused by sunlight, and respiratory reactions (there is a possibility of an asthma attack, especially in people allergic to acetylsalicylic acid and/or other NSAIDs). In such cases, the use of the medicine is contraindicated.
Other possible effects (related to the gastrointestinal tract and kidneys) result from the penetration of the active substance through the skin and are therefore dependent on: the dose of ketoprofen used, the skin surface area, the degree of absorption into the tissue, the duration of treatment, and the use or non-use of a dressing. In some people, other side effects may occur when using Ketospray Forte.
If you experience any side effects, including those not listed in this leaflet, you should tell your doctor or pharmacist. Side effects can be reported directly to the Department of Adverse Reaction Monitoring of Medicinal Products, Medical Devices, and Biocidal Products,
Aleje Jerozolimskie 181C, 02-222 Warsaw, tel. +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl
By reporting side effects, you can help gather more information on the safety of the medicine.
Store in the outer packaging.
Use within 1 year of first opening.
Store out of sight and reach of children.
Do not use the medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the given month.
Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
The active substance of Ketospray Forte is ketoprofen.
1 ml of the medicine contains 100 mg of ketoprofen.
1 dose from the dispenser (0.2 ml) contains 20 mg of ketoprofen.
Other ingredients of the medicine are: propylene glycol, isopropyl alcohol, macrogol 15 hydroxystearate, sodium dihydrogen phosphate dihydrate, disodium phosphate dodecahydrate, sodium hydroxide, peppermint oil, purified water.
Ketospray Forte is a colorless to slightly yellowish, clear solution.
A 30 ml brown glass bottle with a pump dispenser, in a cardboard box.
For more detailed information, you should contact the marketing authorization holder or the parallel importer.
G.T.S. SOLUTION SRL
Calea Rahovei, Nr. 266-268, Corp 3, Axele A-B 1/2
Stălpii 12-14, Camera 09A, Etaj 1, Sector 5
Bucharest, Romania.
PHARBIL WALTROP GmbH
Im Wirrigen 25
45731 Waltrop
Germany
TEMMLER ITALIA S.R.L.
Via delle Industrie
2, Carugate, 20061
Italy
Medezin Sp. z o.o.
ul. Zbąszyńska 3
91-342 Łódź
CEFEA Sp. z o.o. Sp. komandytowa
ul. Działkowa 56
02-234 Warsaw
Pharma Innovations Sp. z o.o.
ul. Jagiellońska 76
03-301 Warsaw
Synoptis Industrial Sp. z o.o.
ul. Szosa Bydgoska 58
87-100 Toruń
CANPOLAND SPÓŁKA AKCYJNA
ul. Beskidzka 190
91-610 Łódź
Medezin Sp. z o.o.
ul. Zbąszyńska 3
91-342 Łódź
Marketing authorization number in Romania, the country of export: 12619/2019/02
Parallel import authorization number: 176/21
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.